This expert blog, written by Upal Basu Roy, MPH, PhD, Director of Translational Research Program/Director of Patient FoRCe at LUNGevity, provides an overview of the latest developments in the treatment of lung cancer presented at the 2018 World Conference for Lung Cancer held in Toronto this summer. Click here to read Dr. Roy's summary of this conference. #ClinicalTrials #LungCancers #NonSmallCellLungCancer #SmallCellLungCancer #JournalArticle #CollaborativePartner #Atezolizumab #CombinationTherapy #ImmuneCheckpointInhibitors #Durvalumab #Clinician #Oncologist #RegisteredNurse #2018#LUNGevity